title: Ketanserin and erythropoiesis in hemodialysis patients with polycystic kidneys.
authors.forename: J
authors.initials: J
authors.lastname: Borawski
authors.forename: M
authors.initials: M
authors.lastname: Mazerska
authors.forename: K
authors.initials: K
authors.lastname: Pawlak
authors.forename: M
authors.initials: M
authors.lastname: Mysliwiec
mesh_terms: D000328:Adult; D004906:Erythrocyte Count; D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000097:blood; D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000209:etiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016891:Polycystic Kidney, Autosomal Dominant / Q000097:blood / Q000150:complications / Q000628:therapy*; D006435:Renal Dialysis; D012702:Serotonin Antagonists / Q000627:therapeutic use*
chemical_list: D012702:Serotonin Antagonists; D004921:Erythropoietin; D007650:Ketanserin